Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002997 · ClinicalTrials.gov registry record · Phase 2
Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer
A Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00002997: Completed Phase 2 study, sponsored by Eastern Cooperative Oncology Group.
NCT00002997 is a Phase 2 study that has completed, run by Eastern Cooperative Oncology Group. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002997, a Phase 2 study, has completed, sponsored by Eastern Cooperative Oncology Group.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Cryosurgery for liver metastases may have fewer side effects and improve recovery. PURPOSE: Phase II trial to study the effectiveness of cryosurgery for patients with unresectable liver metastases from colorectal cancer.
Interventions
- PROCEDURE cryosurgery
Trial Details
| Field | Value |
|---|---|
| Start Date | 1998-02-04 |
| Est. Completion | 2004-03-02 |
| Phase | Phase 2 |
What the finished NCT00002997 record still lists
NCT00002997 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which cryosurgery is the first listed.
NCT00002997 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002997 about?
NCT00002997 is a clinical study titled "Cryosurgery in Treating Patients With Unresectable Liver Metastases From Colorectal Cancer". RATIONALE: Cryosurgery for liver metastases may have fewer side effects and improve recovery. PURPOSE: Phase II trial to study the effectiveness of cryosurgery for patients with unresectable liver metastases from colorectal cancer.
What is the current status of trial NCT00002997?
This trial is currently completed. It is a Phase 2 study. The study started on 1998-02-04. Estimated completion is 2004-03-02.
What interventions are being tested in trial NCT00002997?
The interventions under investigation include: cryosurgery (PROCEDURE).
Who is sponsoring clinical trial NCT00002997?
This trial is sponsored by Eastern Cooperative Oncology Group, which has 141 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI